The effect of exaprolol (MG 8823) on epicardial ST-segment changes in a feline model of acute myocardial ischaemiaPARRATT, J. R; UDVARY, E.British journal of pharmacology. 1983, Vol 80, Num 1, pp 95-105, issn 0007-1188Article

The use of the EEG for assessment of vigilance changes caused by beta-blockersMATOUSEK, M; HJALMARSON, A; KOCH, J et al.Neuropsychobiology. 1984, Vol 12, Num 1, pp 55-59, issn 0302-282XArticle

Effects of beta-receptor blockers in pharmacology EEGESCHMANN, G; IRRGANG, V; RÜTHER, E et al.Neuropsychobiology. 1983, Vol 10, Num 2-3, pp 190-192, issn 0302-282XArticle

Effect of the sialylation state of α₁-acid glycoprotein on propranolol bindingPRIMOZIC, S; MCNAMARA, P. J.Journal of pharmaceutical sciences. 1985, Vol 74, Num 4, pp 473-475, issn 0022-3549Article

Revised HPLC determination of atenolol in plasma and urineGILLILAN, R. B; MASON, W. D.Analytical letters. 1983, Vol 16, Num 12, pp 941-949, issn 0003-2719Article

Recent chemical developments in the field of beta adrenoceptor blocking drugsKÖPPE, H. G.Progress in clinical biochemistry and medicine. 1986, Vol 3, pp 29-72, issn 0177-8757Article

Increased portal venous resistance hinders portal pressure reduction during the administration of β-adrenergic blocking agents in a portal hypertensive modelKROEGER, R. J; GROSZMANN, R. J.Hepatology (Baltimore, Md.). 1985, Vol 5, Num 1, pp 97-101, issn 0270-9139Article

Role of β₂-adrenoceptor blockade and circulating adrenaline level for the pressor responses to β-adrenoceptor blocking drugs in ratsHIMORI, N; ISHIMORI, T; SHIRATSUCHI, K et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 325, Num 4, pp 314-319, issn 0028-1298Article

The psychological side effects of acebutolol and atenololLEWIS, M. J; JONES, D. M; DART, A. M et al.British journal of clinical pharmacology. 1984, Vol 17, Num 3, pp 364-366, issn 0306-5251Article

Le point sur les effets indésirables des bêta-bloquants = Beta blocking agent toxicityCHEYMOL, G; BIOUR, M.La Vie médicale (1969). 1985, Vol 66, Num 4, pp 157-160, issn 0042-5583, 3 p.Article

ADP-induced platelet aggregation and metoprolol treatment of myocardial infarction patients: a controlled studyVILEN, L; KUTTI, J; SWEDBERG, K et al.Acta medica Scandinavica. 1985, Vol 217, Num 1, pp 15-20, issn 0001-6101Article

Carbon-13 nuclear magnetic resonance of some new β-blockers. IABOUL-ENEIN, H. Y; HASSAN, M. M. A; JADO, A. I et al.Spectroscopy letters. 1983, Vol 16, Num 3, pp 151-158, issn 0038-7010Article

METHOTREXATE CEREBROSPINAL FLUID AND SERUM CONCENTRATIONS AFTER INTERMEDIATE DOSE METHOTREXATE INFUSIONEVANS WE; HUTSON PR; STEWART CF et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 301-307; BIBL. 24 REF.Article

CHLORAMPHENICOL SERUM CONCENTRATION FALLS DURING CHLORAMPHERICAL SUCCINATE DOSINGNAHATA MC; POWELL DA.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 308-313; BIBL. 15 REF.Article

DISTRIBUTION AND PROPERTIES OF FC RECEPTORS FOR IGG ON DIFFERENT LEUCOCYTE POPULATION IN MANCOLOMBATTI M; HEUMANN D; MORETTA L et al.1981; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1981; VOL. 46; NO 2; PP. 453-458; BIBL. 18 REF.Article

The pharmacoeconomics of peri-operative beta-blocker therapyBICCARD, B. M; SEAR, J. W; FOËX, P et al.Anaesthesia. 2006, Vol 61, Num 1, pp 4-8, issn 0003-2409, 5 p.Article

Use of 4-(N,N-dimethylaminosulphonyl)-7-fluoro-2,1,3-benzoxadiazole as a labelling reagent for peroxyoxalate chemiluminescence detection and its application to the determination of the β-blocker metoprolol in serum by high-performance liquid chromatographyUZU, S; IMAI, K; NAKASHIMA, K et al.Analyst (London. 1877. Print). 1991, Vol 116, Num 12, pp 1353-1357, issn 0003-2654Article

El uso de beta-bloqueadores en el embarazo = Beta blocking agent and pregnancyROMERO-AYALA, L. C; ZAMORA-GARZA, M; MARTINEZ SANCHEZ, M et al.Archivos del Instituto de Cardiologia de México. 1990, Vol 60, Num 6, pp 593-595, issn 0365-3080Article

Proceedings/Symposium on position of beta blockers in antihypertensive therapy, Monte-Carlo, MCO, March 22-24, 1985BUHLER, F. R.Journal of cardiovascular pharmacology. 1986, Vol 8, pp S1-S87, issn 0160-2446, suppl. 6Conference Proceedings

Chronotropic effects of pindolol: relation between ventricular effects and control resting ventricular rate values in conscious dogs with chronic A-V blockBOUCHER, M; DUBRAY, C; DUCHENE-MARULLAZ, P et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 325, Num 2, pp 183-185, issn 0028-1298Article

Beta-adrenoceptor blockade and anaesthesia for thyroidectomyHAMILTON, W. F. D; FORREST, A. L; GUNN, A et al.Anaesthesia. 1984, Vol 39, Num 4, pp 335-342, issn 0003-2409Article

Bilan de 6 ans d'utilisation des bêta-bloquants dans le traitement des hypertensions artérielles de la grossesse (143 observations relevées de mai 76 à décembre 82) = Six years of use of beta blocking drugs in the treatment of hypertension in pregnancyMONNIER, J. C; VALAT, A. S; LANCIAUX, B et al.LARC médical. 1984, Vol 4, Num 2, pp 61-66, issn 0242-9462Article

Propranolol in the treatment of neuroleptic-induced akathisiaLIPINSKI, J. F. JR; ZUBENKO, G. S; COHEN, B. M et al.The American journal of psychiatry. 1984, Vol 141, Num 3, pp 412-415, issn 0002-953XArticle

Bopindolol: a new long acting β-receptor antagonist; its effects on haemodynamics, and on the renin response to tiltingTURNER, D. R; GOODWIN, F. J; KNIGHT, A. R et al.British journal of clinical pharmacology. 1984, Vol 17, Num 3, pp 295-299, issn 0306-5251Article

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranololLENNARD, M. S; JACKSON, P. R; FREESTONE, S et al.British journal of clinical pharmacology. 1984, Vol 17, Num 6, pp 679-685, issn 0306-5251Article